Versant Ventures VI GP-GP, LLC (CIK 0001777652)

Latest company ownership

Shares held
3,297,115
Last filed at
Aug 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
2,846,941
Last filed at
Jul 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
1,573,453
Last filed at
Oct 30, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
842,162
Last filed at
Oct 2, 2025
Confidence Score
38.3
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
714,095
Last filed at
Aug 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
PASG - Passage BIO, Inc.
Role: 10% Owner
Shares held
708,352
Last filed at
Mar 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
231,211
Last filed at
Jun 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
LVTX - LAVA Therapeutics NV
Role: 10% Owner
Shares held
0
Last filed at
Sep 23, 2025
Confidence Score
40.6
2025Q4
Confidence Score History
2025Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2025 Oct 2, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -224,974 -11.03% ✗ $10.4M
Sep 19, 2025 Sep 23, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -2,903,403 -100.00% ✗ $4.1M
Sep 18, 2025 Sep 22, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -135,304 -6.22% ✗ $5.7M
Sep 16, 2025 Sep 18, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -1,684,434 -36.72% ✗ $2.5M
Aug 22, 2025 Aug 26, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -188,094 -7.96% ✗ $7.4M
Aug 15, 2025 Aug 19, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -260,713 -9.94% ✗ $10.3M
Jul 10, 2025 Jul 14, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -191,376 -5.23% ✗ $6.5M
Jun 27, 2025 Jul 1, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -200,000 -5.18% ✗ $6.1M
Jun 18, 2025 Jun 20, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -334,801 -9.99% ✗ $10.1M
Jun 10, 2025 Jun 12, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -350,000 -9.46% ✗ $10.2M
Oct 28, 2024 Oct 30, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -1,544,352 -12.37% ✗ $1.5M
Sep 20, 2024 Sep 24, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 16.3 -1,132,566 -13.60% ✗ $7.4M
Sep 11, 2024 Sep 13, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -567,213 -6.38% ✗ $3.4M
Aug 8, 2024 Aug 12, 2024 Tempest Therapeutics, Inc. 10% Owner Sell 20.0 -787,999 -18.35% ✗ $967K
Aug 9, 2022 Aug 11, 2022 Century Therapeutics, Inc. 10% Owner Sell 26.3 -914,800 -6.99% ✓ $7.2M
Jun 3, 2022 Jun 7, 2022 Repare Therapeutics Inc. 10% Owner Sell 16.3 -1,450,000 -22.51% ✗ $9.2M
Jun 29, 2021 Jul 1, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 100.0 +180,000 11.78% ✗ $3.1M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 95.0 +157,895 8.14% ✗ $3M
Jun 22, 2021 Jun 23, 2021 Century Therapeutics, Inc. 10% Owner Buy 100.0 +100,000 16.28% ✗ $2M
Jan 7, 2020 Jul 10, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -53,057 -1.83% ✓ $1.1M
Jan 2, 2020 Jul 10, 2020 Akero Therapeutics, Inc. 10% Owner Sell 36.3 -756,587 -2.58% ✓ $1.4M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. 10% Owner Buy 96.3 +250,000 6.62% ✗ $5M
Mar 3, 2020 Mar 3, 2020 Passage BIO, Inc. 10% Owner Buy 100.0 +225,000 31.76% ✗ $4.1M
Jan 16, 2020 Jan 21, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -59,532 -1.89% ✓ $1.2M
Jan 10, 2020 Jan 15, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -50,837 -1.59% ✓ $1M
Jan 7, 2020 Jan 9, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -53,057 -1.63% ✓ $1.1M
Jan 2, 2020 Jan 6, 2020 Akero Therapeutics, Inc. 10% Owner Sell 36.3 -756,587 -2.32% ✓ $1.4M